This company listing is no longer active
LH.WI Stock Overview
Operates as a laboratory services company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Labcorp Holdings Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$207.45 |
| 52 Week High | US$208.88 |
| 52 Week Low | US$200.00 |
| Beta | 1.04 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 3.72% |
Recent News & Updates
Recent updates
Shareholder Returns
| LH.WI | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 3.2% | -0.9% | 0.5% |
| 1Y | n/a | 2.7% | 23.9% |
Return vs Industry: Insufficient data to determine how LH.WI performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how LH.WI performed against the US Market.
Price Volatility
| LH.WI volatility | |
|---|---|
| LH.WI Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.5% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in US Market | 15.4% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: LH.WI has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine LH.WI's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 75,200 | Adam Schechter | www.labcorp.com |
Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics and Labcorp Drug Development. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests.
Labcorp Holdings Inc. Fundamentals Summary
| LH.WI fundamental statistics | |
|---|---|
| Market cap | US$18.51b |
| Earnings (TTM) | US$1.00b |
| Revenue (TTM) | US$14.76b |
18.5x
P/E Ratio1.3x
P/S RatioIs LH.WI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LH.WI income statement (TTM) | |
|---|---|
| Revenue | US$14.76b |
| Cost of Revenue | US$10.63b |
| Gross Profit | US$4.13b |
| Other Expenses | US$3.13b |
| Earnings | US$1.00b |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
Jul 27, 2023
| Earnings per share (EPS) | 11.29 |
| Gross Margin | 27.97% |
| Net Profit Margin | 6.78% |
| Debt/Equity Ratio | 52.3% |
How did LH.WI perform over the long term?
See historical performance and comparison